glp 1 mechanism of action diabetes GLP-1 Agonists For Obesity In Non-Diabetic Patients: Game Changer Or Overhyped? A Critical Analysis GlobalRPH Mechanisms of GLP-1 Receptor Agonist-Induced

JAMA Oncol

Some patients report reduced symptoms of inflammation after the very first dose -meaning it cant be due to weight loss or improved insulin sensitivity yet

Common gastrointestinal side effects occur in many patients and include: Nausea (most common, typically improving after 4-8 weeks) Vomiting Diarrhea Constipation Abdominal pain or discomfort Decreased appetite These effects result from the drugs' mechanism of actionslowing gastric emptying and affecting gut motilityrather than indicating tissue damage or malignancy

However, Eggers test detected a significant risk of publication bias in MCI brain GSH literature (bias [95%CI] = 11.28 [20.6, 1.95], p =0.03) and AD blood GSH literature (bias [95%CI] = 5.18 [9.96, 0.40], p =0.035)